New: our quarterly report on the S&P 500, read from 500 companies’ own filings and calls.
Read the Q3 2026 report
Intellia Therapeutics, Inc. (NTLA) vs Tyra Biosciences, Inc. (TYRA)
- Intellia Therapeutics, Inc. NTLA 10.10 +5.76%
- Tyra Biosciences, Inc. TYRA 19.97 +1.22%
Intellia Therapeutics, Inc. and Tyra Biosciences, Inc. are both Biotechnology companies. Intellia Therapeutics, Inc. and Tyra Biosciences, Inc. are of similar size ($1.4B and $1.3B). Tyra Biosciences, Inc. has the higher net margin (0.00% vs −805.8%) and the higher return on invested capital (0.00% vs −195.3%). Across the 13 metrics below, Tyra Biosciences, Inc. leads on 10 and Intellia Therapeutics, Inc. on 3.
Valuation
Profitability
| Metric | NTLA | TYRA | Biotechnology median |
|---|---|---|---|
| Gross margin | 100.00% | 0.00% | 70.18% |
| Operating margin | (821.24%) | 0.00% | 0.00% |
| Net margin | (805.75%) | 0.00% | 0.00% |
| Free cash flow margin | (676.38%) | 0.00% | 0.00% |
| Return on equity | (62.60%) | (34.89%) | (51.58%) |
| Return on assets | (46.63%) | (32.99%) | (45.91%) |
| Return on invested capital | (195.32%) | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack